Common use of SCIENTIFIC REPORTS Clause in Contracts

SCIENTIFIC REPORTS. (a) NeoGenesis will keep and maintain adequate records containing laboratory data generated in the course of the Screening Program to enable it to furnish complete and accurate information to Immusol regarding the Screening Program activities and results, including all Program Intellectual Property described in clauses (a) or (b) of the Program Intellectual Property definition. All such written records of NeoGenesis shall be open to inspection by Immusol during normal business hours upon reasonable prior notice. (b) NeoGenesis shall provide Immusol with reasonably-detailed written reports describing the results of the research performed pursuant to the Screening Program including all Program Intellectual Property described in clauses (a) or (b) of the Program Intellectual Property definition. Such reports shall be delivered to Immusol at least quarterly during the Screening Program. Representatives of NeoGenesis will make themselves reasonably available to discuss such reports and the progress of the Screening Program. NeoGenesis will deliver a Final Target Report (as defined in ATTACHMENT A) with respect to the Screening Program work performed on each Shared Target.

Appears in 2 contracts

Sources: Collaboration Agreement (Neogenesis Pharmaceuticals Inc), Confidential Treatment Agreement (Neogenesis Pharmaceuticals Inc)